Table 4.
Percentage of benzodiazepine users (aged 0–15 years) from 2002 to 2011 taking concomitant medications
| Year | Benzodiazepine users (n) |
Concomitant antipsychotics n (%) |
Concomitant antiepileptics n (%) |
Concomitant antidepressants n (%) |
Concomitant psychostimulants n (%) |
|---|---|---|---|---|---|
| 2002 | 2127 | 81 (3.81) | 498 (23.41) | 272 (12.79) | 20 (0.94) |
| 2003 | 2154 | 87 (4.04) | 553 (25.67) | 266 (12.35) | 35 (1.62) |
| 2004 | 1990 | 84 (4.22) | 572 (28.74) | 215 (10.80) | 21 (1.06) |
| 2005 | 2031 | 91 (4.48) | 633 (31.17) | 219 (10.78) | 45 (2.22) |
| 2006 | 1928 | 92 (4.77) | 556 (28.84) | 215 (11.15) | 37 (1.92) |
| 2007 | 1916 | 116 (6.05) | 579 (30.22) | 204 (10.65) | 36 (1.88) |
| 2008 | 1895 | 91 (4.80) | 549 (28.97) | 213 (11.24) | 51 (2.69) |
| 2009 | 1996 | 116 (5.81) | 550 (27.56) | 211 (10.57) | 50 (2.51) |
| 2010 | 1951 | 95 (4.87) | 528 (27.06) | 222 (11.38) | 36 (1.85) |
| 2011 | 2067 | 130 (6.29) | 557 (26.95) | 255 (12.34) | 40 (1.94) |
Percentage of benzodiazepine users aged 0–15 years who also received concomitant antipsychotics (column 3) or antiepileptics (column 4) or antidepressants (column 5) or psychostimulants (column 6) medication from 2002 to 2011.